207 related articles for article (PubMed ID: 27600285)
41. Effect of two intensive statin regimens on progression of coronary disease.
Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
[TBL] [Abstract][Full Text] [Related]
42. Roles of endothelial lipase gene related single nucleotide polymorphisms in patients with coronary artery disease.
Abudureyimu S; Abulaiti P; Li H; Xing Z; Liu S; Li W; Gao Y
Gene; 2021 Jul; 788():145669. PubMed ID: 33882321
[TBL] [Abstract][Full Text] [Related]
43. Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia.
Ding C; Hu M; Wu YJ; Tomlinson B
Lipids Health Dis; 2015 Sep; 14():107. PubMed ID: 26365713
[TBL] [Abstract][Full Text] [Related]
44. High-density lipoprotein subfractions and influence of endothelial lipase in a healthy Turkish population: a study in a land of low high-density lipoprotein cholesterol.
Kilic H; Atalar E; Lay I; Yazihan N; Buyukcam F; Saygisunar U; Aksoy M; Gunduz H; Akdemir R
Scand J Clin Lab Invest; 2014 Jun; 74(4):278-84. PubMed ID: 24479875
[TBL] [Abstract][Full Text] [Related]
45. [Geographical characteristics of single nucleotide polymorphism of candidate genes associated with coronary artery disease in Chinese Han population].
Wang SH; Cui HB; Wang DQ; Chen XM; Zhang HK; Cui CC; Chen XY; Liu XH; Zhang Z; Bai F; Jb M
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):24-9. PubMed ID: 19099922
[TBL] [Abstract][Full Text] [Related]
46. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.
Zambon A; Deeb SS; Brown BG; Hokanson JE; Brunzell JD
Circulation; 2001 Feb; 103(6):792-8. PubMed ID: 11171785
[TBL] [Abstract][Full Text] [Related]
47. Association of 584C/T polymorphism in endothelial lipase gene with risk of coronary artery disease.
Elnaggar IZ; Hussein S; Amin MI; Abdelaziz EA
J Cell Biochem; 2019 Sep; 120(9):14414-14420. PubMed ID: 31020688
[TBL] [Abstract][Full Text] [Related]
48. Comparison of atorvastatin, pitavastatin and rosuvastatin for residual cardiovascular risk using non-fasting blood sampling.
Kakuda H; Matoba M; Nakatoh H; Nagao S; Takekoshi N
Scand J Clin Lab Invest; 2014 Jun; 74(4):285-95. PubMed ID: 24564634
[TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein M T-778C polymorphism is associated with serum lipid levels and the risk of coronary artery disease in the Chinese population: a meta-analysis.
Zhang Z; Chu G; Yin RX
Lipids Health Dis; 2013 Sep; 12():135. PubMed ID: 24040766
[TBL] [Abstract][Full Text] [Related]
50. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
[TBL] [Abstract][Full Text] [Related]
51. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of rosuvastatin versus atorvastatin in high-risk Chinese patients with hypercholesterolemia: a randomized, double-blind, active-controlled study.
Zhao S; Peng D
Curr Med Res Opin; 2018 Feb; 34(2):227-235. PubMed ID: 28836458
[TBL] [Abstract][Full Text] [Related]
53. Cholesterol ester transfer protein, apolipoprotein E and lipoprotein lipase genotypes in patients with coronary artery disease in the Turkish population.
Isbir T; Yilmaz H; Agachan B; Karaali ZE
Clin Genet; 2003 Sep; 64(3):228-34. PubMed ID: 12919138
[TBL] [Abstract][Full Text] [Related]
54. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.
Deguchi I; Horiuchi Y; Hayashi T; Sehara Y; Kato Y; Ohe Y; Fukuoka T; Maruyama H; Sano H; Nagamine Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2007-2011. PubMed ID: 25066602
[TBL] [Abstract][Full Text] [Related]
55. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
56. Periodic rosuvastatin or atorvastatin dosing arrays (PRADA): patient-centered practice.
Christou T; Omar HR; Dimitrov R
Drugs R D; 2014 Dec; 14(4):221-5. PubMed ID: 25160776
[TBL] [Abstract][Full Text] [Related]
57. Hepatic lipase C514T polymorphism and its relationship with plasma HDL-C levels and coronary artery disease in Koreans.
Park KW; Choi JH; Chae IH; Cho HJ; Oh S; Kim HS; Lee MM; Park YB; Choi YS
J Biochem Mol Biol; 2003 Mar; 36(2):237-42. PubMed ID: 12689525
[TBL] [Abstract][Full Text] [Related]
58. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
[TBL] [Abstract][Full Text] [Related]
59. Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease.
Toyama K; Sugiyama S; Oka H; Iwasaki Y; Sumida H; Tanaka T; Tayama S; Jinnouchi H; Matsui K; Ogawa H
Atherosclerosis; 2011 Jul; 217(1):158-64. PubMed ID: 21458815
[TBL] [Abstract][Full Text] [Related]
60. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
